Steven Daniel Daveluy, MD, FAAD
SESSIONS
U014 Using Artificial Intelligence for Rare Dermatologic Diseases: Getting the Right Patients the Right Treatment at the Right Time
Mar 7, 2025
•
7:30 AM - 8:30 AM
•
W303A
C002 Conquer the Boards: Core Exam & Review
Mar 7, 2025
•
9:00 AM - 12:00 PM
•
W202C
C006 Conquer the Boards: Applied Exam & Review
Mar 7, 2025
•
1:00 PM - 4:00 PM
•
W202C
F033 DataDerm 2.0 – a new era of leveraging technology to add value to patients and practices
Mar 8, 2025
•
9:00 AM - 11:00 AM
•
W414C
F043 Data-Driven Dermatology: Mastering MIPS and Improving Practice Quality
Mar 8, 2025
•
1:00 PM - 3:00 PM
•
W208A
F050 Dietary Triggers and Modifications of Common Dermatologic Conditions: An Evidence Based Approach
Mar 8, 2025
•
3:30 PM - 5:30 PM
•
Valencia Ballroom B
S042 LGBTQ/SGM Health in Dermatology: Essentials and Updates
Mar 9, 2025
•
1:00 PM - 4:00 PM
•
W304E
U097 In Office Surgical Techniques for the Treatment of Moderate to Severe Hidradenitis Suppurativa (HS)
Mar 10, 2025
•
7:30 AM - 8:30 AM
•
W207A
HANDOUTS
Login to view handouts
DISCLOSURES
AbbVie – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Incyte – Advisory Board(Honoraria); Insmed – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Novartis – Speaker(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); UCB – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Honoraria);